LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

NVS

144.93

-0.69%↓

MRK

111.34

+0.09%↑

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

NVS

144.93

-0.69%↓

MRK

111.34

+0.09%↑

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

NVS

144.93

-0.69%↓

MRK

111.34

+0.09%↑

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

NVS

144.93

-0.69%↓

MRK

111.34

+0.09%↑

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

NVS

144.93

-0.69%↓

MRK

111.34

+0.09%↑

Inicio・Lista de Acciones・Dynavax Technologies Corp
Search

Dynavax Technologies Corp

Cerrado

SectorSanidad

15.49

Precios actualizados 9 feb 2026, 14:31 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

15.49

Máximo

15.49

Métricas clave

By Trading Economics

Ingresos

8.2M

27M

Ventas

-566K

95M

Margen de beneficios

28.381

Empleados

405

EBITDA

7M

32M

Dividendos

By Dow Jones

Próximas Ganancias

19 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

625M

1.8B

Apertura anterior

15.49

Cierre anterior

15.49

Noticias sobre sentimiento de mercado

By Acuity

18%

82%

26 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

9.62 / 10.9 Soporte y Resistencia

Dynavax Technologies Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 dic 2025, 11:40 UTC

Adquisiciones, fusiones, absorciones

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal -- Update

DJ

Leer

24 dic 2025, 11:17 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Dynavax Shares Leap Premarket on Takeover by Sanofi

DJ

Leer

24 dic 2025, 06:55 UTC

Adquisiciones, fusiones, absorciones

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

DJ

Leer

12 ene 2026, 19:24 UTC

Adquisiciones, fusiones, absorciones

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

DJ

Leer

12 ene 2026, 19:22 UTC

Adquisiciones, fusiones, absorciones

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

DJ

Leer

24 dic 2025, 17:08 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

DJ

Leer

24 dic 2025, 12:59 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

DJ

Leer

24 dic 2025, 06:41 UTC

Adquisiciones, fusiones, absorciones

Correct: Sanofi: Deal Expected to Have No Impact on 2025 Guidance

DJ

Leer

24 dic 2025, 06:19 UTC

Adquisiciones, fusiones, absorciones

Sanofi: Acquisition to Close in 1Q of 2026

DJ

Leer

24 dic 2025, 06:19 UTC

Adquisiciones, fusiones, absorciones

Sanofi: Deal Expected to Have on Impact on 2025 Guidance

DJ

Leer

24 dic 2025, 06:19 UTC

Adquisiciones, fusiones, absorciones

Sanofi: Offering $15.50 a Share in Cash for Dynavax

DJ

Leer

24 dic 2025, 06:18 UTC

Adquisiciones, fusiones, absorciones

Sanofi to Start Cash Tender Offer at Equity Value of $2.2B

DJ

Leer

24 dic 2025, 06:18 UTC

Adquisiciones, fusiones, absorciones

Sanofi: Deal Adds Marketed Adult Hepatitis B Vaccine, Phase 1/2 Shingles Candidate

DJ

Leer

24 dic 2025, 06:17 UTC

Adquisiciones, fusiones, absorciones

Sanofi to Buy Vaccine Company Dynavax Technologies

DJ

Leer

24 dic 2025, 06:16 UTC

Adquisiciones, fusiones, absorciones

Sanofi to Buy Dynavax

DJ

Leer

Comparación entre iguales

Cambio de precio

Dynavax Technologies Corp previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Dynavax Technologies Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.62 / 10.9Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Largo Plazo

Strong Bearish Evidence

All events are bearish.

Sentimiento

By Acuity

26 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

Otras acciones del sector

LLY

Eli Lilly and Co.

966.35

↑ +1.98%

JNJ

Johnson and Johnson

221.39

↑ +0.12%

ABBV

AbbVie Inc

202.82

↑ +0.84%

NVS

Novartis AG

144.93

↓-0.69%

MRK

Merck & Co Inc.

111.34

↑ +0.09%
help-icon Live chat